##
##
##
||Page|
|---|---|
|Reference an/ administrative
details ofthe charity, its Trustees and advisers||
|Trustees'
report|2-9|
|Independent
examiner's
report|10|
|Statement offinancial activities||
|Balance sheet|12|
|Notes tothe financial statements|13-20|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Top|Ten Researc|h Priorit|ies||
|---|---|---|---|---|
||Short Title||Full Priority Wording||
||||What strategies
can increase awareness
and understanding
ofDCM amongst||
||Raising Awareness||healthcare
professionals
and the public? Can these strategies
help improve||
||||timely dia nosis and management
ofDCM?||
||||What is the natural
history ofDCM? What is the relationship
between
DCM|and|
|2|Natural
History||asymptomatic
spinal cord compression
or canal stenosis'? What factors||
||||Inliuence the natural
history ofthe disease?||
|3|Diagnostic|Cdteria|What is are the diagn'ostic
criteria ofDCM? What is the role ofimaging
and
when should
imaging be used in the assessment
ofDCM?||
||||What assessment
tools can be used to evaluate
functional
impairment,||
||Assessment|and|disability
and quality oflife in people with DCM? What instruments,
tools or||
||Monitoring||methods
can be used or developed to monitor people with DCM Ibr disease||
||||progression
or improvement
either before orafter surgical treatment?||
|5|Pathophysiology||What is the pathophysiology
of DCM'? What are the mechanisms
of
neurological
injuly and. the molecular
and anatomical
consequences?||
||||What is the role of rehabilitation
following
surgery
for DCM'? Can structured||
|6|Rehabilitation||postoperative
rehabilitation
improve outcome following
surgery
for DCM? What||
||||are the most effective strategies'?||
||||Can novel therapies,
including
stem-cell, gene, pharmacoiogical
and||
|7|Novel Therapies||neuroprotective
therapies,
improve the health and wellbeing
ofpeople
living with||
||||DCM and slow down disease progression?||
||Socio-economic||What is the socio-economic
impact of DCM'? (The hnancial impact ofliving|vvith|
||Impact||OClM to the individual,
their supporters
and sociefy as a vAole)||
||Imaging
Techniques||What is the role ofdynamic
or novel imaging techniques
and neurophysiology
the assessment
ofDCM?|in|
|10|Individualising
Sugary||Are there clinical and imaging
factors that can help a surgeon select who should
undergo
surgical decompression
in the setting ofDCM? At what stage ofthe
disease is surgery
the preferred
management
strategy' ?||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||Restricted|Unrestricted||'Total|Total|
|---|---|---|---|---|---|---|---|---|
|||||funds|funds||funds|funds|
|||||2022|2022||2022|2021|
||||Note|f.|||||
|Income from:|||||||||
|Donations||||4,524|741829||79,353|118,317|
|Charitable
activities|||||2,252||2,252|4,946|
|Investments|||||3||3|21|
|Total income||||4,524|77,084|||123,284|
|Expenditure
on:|||||||||
|Raising funds|||||3,785||3,785|1,842|
|Charitable
activities||||8,618|69,939||78,557|73,512|
|Total expenditure||||8,618|73,724||82,342|75,354|
|Net movement|in funds|||(4,094)|3,360||(734)|47,930|
|Reconciliation|offunds:||||||||
|Total funds brought||forward||4,094|52,329||56,423|8,493|
|Net movement|in funds|||(4,094)|3,360||(734)|47,930|
|Total funds carried forvvard|||||55s689|' '|55&689|56r423|
##
##
##
##
##
##
##
##
##
##
##
||Restricted|Unrestricted|Total|Total|
|---|---|---|---|---|
||funds|funds|funds|funds|
||2022|2022|2022|2021|
||||F||
|Donations||73,829|73,829|106,229|
|Grants|4,524|1,000|5,524|12,088|
||4,524|74,829|79,353|l18,317|
|Total 2021|12,088|106,229|118,317||
##
##
|Unrestricted|Total|Total|
|---|---|---|
|funds|funds|funds|
|2022|2022|2021|
|2,252|2,252|4,946|
##
|Unrestricted|Total|Total|
|---|---|---|
|funds|funds|funds|
|2022|2022|2021|
##
##
##
|Unrestricted|Total|Total|
|---|---|---|
|funds|'funds|funds|
|2022|2022|2021|
|3,785|3,785|1,S42|
##
|||Activities||||
|---|---|---|---|---|---|
|||undertaken|Suppott|Total|Total|
|||directly|costs|funds|funds|
|||2022|2022|2022|2021|
|||||R||
|Charitable|activities|2,695|75,862|78,557|73,512|
|Total 2021||5,964|67,54S|73;512||
##
||Charitable|Total|Total|
|---|---|---|---|
||activities|funds|funds|
||2022|2022|2021|
|||K||
|Education|2,538|2,538|3,095|
|Research|157|$57|2,869|
||2,695|2,695|5,964|
##
##
##
|||Charitable|Total|Total|
|---|---|---|---|---|
|||activities|funds|funds|
|||2D22|2D22|2021|
|Staff costs||14,291|14,291||
|General office expenses||584|584|71|
|Computer expenses||1,000|1,DQD|768|
|Insurance||426|426|398|
|Subscriptions||194|194|f57|
|Travel and subsistence||72|72||
|Grant funded|Google advertisements|49,920|49,92Q|50,5f9|
|Consultancy||8,115|8,115|14,375|
|Governance|costs|1,260|1,26D|1,260|
|||75,862|75,862|67,548|
##
##
##
##
##
|||2022|2021|
|---|---|---|---|
|Trade debtors||2,252||
|Prepayments|and accrued income|167|149|
|Tax recoverable||625|5,000|
|Grants receivable|||2,088|
|||3,044|?,23?|
##
##
##
##
|||2022|202$|
|---|---|---|---|
|Trade creditors||1,040|1,875|
|Accruals and deferred|income|1,200|3,200|
|||2,240|5,075|
##
|Statement offunds|- current year|||||
|---|---|---|---|---|---|
||||||Balance at|
|||Balance at 1|||30June|
|||July 2021|Income|Expenditure|2022|
|||||R||
|Unrestricted
funds||||||
|General Funds||52,329|T7,084|(73,T24)|55,689|
|Restricted funds||||||
|Facing Myelopathy|Together|4,094||(4,094)||
|DCM COINS Project|||4,524|(4,524)||
|||4,094|4,524|(8,618)||
|Total offunds||56,423|81,698|}82,342}|55,689|
##
##
##
##